BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Espeseth AS, Yuan M, Citron M, Reiserova L, Morrow G, Wilson A, Horton M, Rukhman M, Kinek K, Hou F, Li SL, Li F, Choi Y, Heidecker G, Luo B, Wu G, Zhang L, Strable E, DeStefano J, Secore S, Mukhopadhyay TK, Richardson DD, Sayeed E, Welch LS, Bett AJ, Feinberg MB, Gupta SB, Cooper CL, Parks CL. Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera. EBioMedicine 2022;82:104203. [PMID: 35915046 DOI: 10.1016/j.ebiom.2022.104203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 He W, Cui H, Wang S, Liang B, Zhang C, Wang W, Wang Q, Li W, Zhao Y, Wang T, Liu Z, Liu B, Yan F, Yang S, Xia X. Characterization of a Vesicular Stomatitis Virus-Vectored Recombinant Virus Bearing Spike Protein of SARS-CoV-2 Delta Variant. Microorganisms 2023;11. [PMID: 36838396 DOI: 10.3390/microorganisms11020431] [Reference Citation Analysis]
2 Ton C, Stabile V, Carey E, Maraikar A, Whitmer T, Marrone S, Afanador NL, Zabrodin I, Manomohan G, Whiteman M, Hofmann C. Development and scale-up of rVSV-SARS-CoV-2 vaccine process using single use bioreactor. Biotechnol Rep (Amst) 2023;37:e00782. [PMID: 36687766 DOI: 10.1016/j.btre.2023.e00782] [Reference Citation Analysis]
3 Gillespie PF, Wang Y, Hofmann C, Kuczynski LE, Winters MA, Teyral JL, Tubbs CM, Shiflett K, Patel N, Rustandi RR. Understanding the Spike Protein in COVID-19 Vaccine in Recombinant Vesicular Stomatitis Virus (rVSV) Using Automated Capillary Western Blots. ACS Omega 2023;8:3319-28. [PMID: 36685032 DOI: 10.1021/acsomega.2c06937] [Reference Citation Analysis]
4 O’donnell KL, Gourdine T, Fletcher P, Clancy CS, Marzi A. Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1025500] [Reference Citation Analysis]
5 Cooper CL, Morrow G, Yuan M, Coleman JW, Hou F, Reiserova L, Li SL, Wagner D, Carpov A, Wallace-selman O, Valentin K, Choi Y, Wilson A, Kilianski A, Sayeed E, Agans KN, Borisevich V, Cross RW, Geisbert TW, Feinberg MB, Gupta SB, Parks CL. Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical Trials. Vaccines 2022;10:1582. [DOI: 10.3390/vaccines10101582] [Reference Citation Analysis]